Fundz

Exero Medical raised $12.7M in a preferred seed financing led by Longevity Venture Partners to support clinical and commercial activities for its xBar system in the U.S.

PRIVATEFeb 13, 2025

Amount Raised

$12.7 Million

Round Type

Seed

Or YehudaBiotechnologyHealth CareMedical

Investors

Tech Council VenturesEdge Medical VenturesLongevity Venture Partners

Description

Exero Medical has secured up to $12.7M in funding to complete its FDA pivotal trial and launch its xBar system in the United States. The round includes $10M in upfront funding and additional milestone-based warrants, along with $2.7M in non-dilutive grants.

Quick answer

Exero Medical raised $12.7 Million in a Seed round, dated February 13, 2025. Investors: Tech Council Ventures, Edge Medical Ventures and Longevity Venture Partners. Exero Medical is based in Or Yehuda, Tel Aviv District, Israel.

How much did Exero Medical raise?
Exero Medical raised $12.7 Million in a Seed round on February 13, 2025.
Who invested in Exero Medical?
Tech Council Ventures, Edge Medical Ventures and Longevity Venture Partners are named as investors in this round.
What does Exero Medical do?
Exero Medical's mission is to empower health care providers with high-quality, actionable post-operative tissue healing data that can save lives, improve prognosis, and reduce cost of care.
Where is Exero Medical based and how big is it?
Exero Medical is based in Or Yehuda, Tel Aviv District, Israel.
Who are the decision-makers at Exero Medical?
Fundz holds 2 contacts at Exero Medical. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Biotechnology around the same time

Companies in the same sectors as Exero Medical that raised within 45 days of this round, from Fundz verified event records.

  • NeOnc Technologies raised $1.6M (Seed) on March 26, 2025.
  • Tenon Medical raised $2.5M on March 25, 2025.
  • Evident Vascular raised an undisclosed amount (Series B) on March 25, 2025.
  • Tenon Medical raised $1.5M on March 25, 2025.
  • Stride raised an undisclosed amount (Series A) on March 24, 2025.
  • Innventure raised $29M on March 24, 2025.

Who to call at Exero Medical, and when

A new round usually means Exero Medical is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Exero Medical raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Exero Medical, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Exero Medical. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Exero Medical

Location

Or Yehuda, Tel Aviv District, Israel

About

Exero Medical's mission is to empower health care providers with high-quality, actionable post-operative tissue healing data that can save lives, improve prognosis, and reduce cost of care. The company's flagship product, the xBar system, has been granted Breakthrough Device Designation by the FDA. Exero Medical was founded in 2018 by MEDX Xelerator, and is backed by the Israeli Innovation Authority, Tech Council Ventures, Longevity Venture Partners, Edge Medical Ventures, Consensus Business Group (CBG), Unorthodox Ventures, and Clalit Health Services – the largest HMO in Israel.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Exero Medical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for Exero Medical's next move

See what Strategic adds

Exero Medical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.